| 摘要 |
The present invention relates to a composition for treating, preventing or relieving macular degeneration, containing a Vaccinium uliginosum extract or Vaccinium uliginosum fractions as an active ingredient. The Vaccinium uliginosum extract and Vaccinium uliginosum fractions, which are active ingredients of the present invention, suppress the accumulation of A2E on retinal pigment epithelial cells and inhibit the oxidation of A2E to effectively protect retinal pigment epithelial cells, and thereby prevent the cause of macular degeneration. Therefore, the composition of the present invention can be developed into various products such as a pharmaceutical, a dietary supplement, and the like, for excellently treating or relieving macular degeneration. |
